:max_bytes(133120)/d2j5s05om7evfr.cloudfront.net/pubmed-llm-images/40009091/aec095d88ed77562842dd0e079ec5184_wm.png)
Pharmacological modulation of PI3K/PTEN/Akt/mTOR/ERK signaling pathways in ischemic injury: a mechanistic perspective.
Summary: Imagine your body’s blood vessels are like a highway system. Sometimes, a traffic jam (a blockage) stops blood from reaching vital areas like your brain or heart. This is called ischemia. Surprisingly, when the blockage clears and blood rushes back in, it can cause even more damage to the cells.
Scientists are studying a specific "communication line" inside your cells called the PI3K pathway. Think of it as a master switch. When medicines turn this switch on correctly, it tells brain and heart cells to repair themselves and survive the stress of the blockage. This review explains how targeting this switch could lead to new treatments for strokes and heart attacks.
Tags
Cerebrovascular Disorders
Cerebral Hemorrhage
Ischemic Stroke
Hemorrhagic Stroke
Wounds and Injuries
Subarachnoid Hemorrhage
Vascular Malformations
Hemorrhage
Disease
Stroke
Aneurysm
Ischemia
Tissue Survival